This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ICL Group (ICL) Earnings and Revenues Surpass Estimates in Q1
by Zacks Equity Research
ICL Group's (ICL) Q1 performance was driven by higher demand and increased prices in most markets.
ICL Group (ICL) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
ICL Group (ICL) delivered earnings and revenue surprises of 45.45% and 19.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ICL Group (ICL) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
ICL Group (ICL) is likely to have benefited from the strength in its specialties businesses and an upside in commodity prices in Q1.
ICL Group (ICL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
ICL Group (ICL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons Why Israel Chemicals (ICL) Is a Great Growth Stock
by Zacks Equity Research
Israel Chemicals (ICL) possesses solid growth attributes, which could help it handily outperform the market.
Has Israel Chemicals (ICL) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Israel Chemicals (ICL) and Mercer International (MERC) have performed compared to their sector so far this year.
Israel Chemicals (ICL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Israel Chemicals (ICL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Oil Slumps More Than 20% From Recent High: ETFs to Win/Lose
by Sanghamitra Saha
After hitting massive highs early this month, oil recently slumped on a number of factors. These sector ETFs may gain/lose on the oil's recent move.
Is Israel Chemicals (ICL) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Israel Chemicals (ICL) could produce exceptional returns because of its solid growth attributes.
Here is Why Growth Investors Should Buy Israel Chemicals (ICL) Now
by Zacks Equity Research
Israel Chemicals (ICL) possesses solid growth attributes, which could help it handily outperform the market.
FMC (FMC) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of 6.93% and 3.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
5 Chemical Stocks Likely to Outshine Q4 Earnings Estimates
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to have been reflected in the Q4 performance of Huntsman (HUN), Chemours (CC), Westlake (WLK), ICL Group (ICL) and Green Plains (GPRE).
Will Israel Chemicals (ICL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Israel Chemicals (ICL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Specialty Chemical Stocks to Buy Despite Supply-Chain Snarls
by Anindya Barman
Although the specialty chemical industry is grappling with higher costs related to supply-chain and logistics disruptions, higher demand across key markets augurs well for the industry in 2022. ASIX, HWKN, ICL and LTHM are worth betting on.
Has Haynes International (HAYN) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Haynes International (HAYN) and Israel Chemicals (ICL) have performed compared to their sector so far this year.
ICL or LTHM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICL vs. LTHM: Which Stock Is the Better Value Option?
Israel Chemicals (ICL) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Israel Chemicals (ICL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ICL vs. NVZMY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ICL vs. NVZMY: Which Stock Is the Better Value Option?
5 Valuable Price-to-Book Stocks to Add to Your Portfolio
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high-growth prospects. ASE Technology Holding (ASX), AdaptHealth Corp. (AHCO), ICL Group (ICL), Conn's (CONN) and Atlas Corp. (ATCO) are some such picks.
Israel Chemicals (ICL) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Israel Chemicals (ICL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ICL vs. NVZMY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ICL vs. NVZMY: Which Stock Is the Better Value Option?
7 Valuable Price-to-Book Stocks to Buy in November
by Kinjel Shah
The P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high-growth prospects.
What Makes Israel Chemicals (ICL) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Israel Chemicals (ICL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks.com featured highlights include: Grupo Financiero Galicia, First Bank, ICL Group and CrossFirst Bankshares
by Zacks Equity Research
Zacks.com featured highlights include: Grupo Financiero Galicia, First Bank, ICL Group and CrossFirst Bankshares
4 Affordable Breakout Stocks for Explosive Returns
by Nitish Marwah
GGAL, FRBA, ICL, and CFB qualified the screen for breakout stocks for today.